Concepta (CPT)

Sector:

Health Care

Index:

FTSE AIM All-Share

 1.40p
   
  • Change Today:
      0.000p
  • 52 Week High: 4.00p
  • 52 Week Low: 1.30p
  • Currency: UK Pounds
  • Shares Issued: 264.95m
  • Volume: 0
  • Market Cap: £3.71m
  • RiskGrade: 390

Concepta to supply 'myLotus' to Walgreens Boots Alliance

By Josh White

Date: Tuesday 12 Mar 2019

LONDON (ShareCast) - (Sharecast News) - Concepta has agreed to supply the 'myLotus' product to Walgreens Boots Alliance, for women's fertility and hormone testing, it announced on Tuesday.
The AIM-traded firm described myLotus as a "revolutionary" home based, self-test product, which was launched in November last year with early 'trying to conceive' users providing personal video feedback and testimonials on their menstrual cycle hormone changes and hormone patterns, enabling women to better understand their menstrual cycle and fertility journey.

It said the supply agreement represented the first commercial partnership forming part of its European Union roll-out plans.

MyLotus recently received CE-mark certification, with the agreement allowing the company to extend its UK relationship with Boots retail stores to other Walgreens Boots Alliance partners across EU markets.

The product was available to women who were planning to start a family, or for those who had previously struggled to naturally conceive, enabling couples an alternative prior to considering more costly IVF treatment.

Concepta expected to release further hormone health and wellbeing tests to complement its fertility offering later in the year.

"We are delighted to work with such a respected British high-street brand and retailer and look forward to supplying myLotus to Boots the Chemist to help improve the chances of a natural pregnancy," said Concepta chairman Matthew Walls.

"We are now preparing our EU market roll-out plans and will update the market in due course."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Concepta Market Data

Currency UK Pounds
Share Price 1.40p
Change Today 0.000p
% Change 0.00 %
52 Week High 4.00p
52 Week Low 1.30p
Volume 0
Shares Issued 264.95m
Market Cap £3.71m
RiskGrade 390

Concepta Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
32.52% below the market average32.52% below the market average32.52% below the market average32.52% below the market average32.52% below the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average
Price Trend
91.45% below the market average91.45% below the market average91.45% below the market average91.45% below the market average91.45% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Income Not Available
Growth
27.49% below the market average27.49% below the market average27.49% below the market average27.49% below the market average27.49% below the market average
11.76% below the sector average11.76% below the sector average11.76% below the sector average11.76% below the sector average11.76% below the sector average

Concepta Dividends

No dividends found

Trades for --2020

Time Volume / Share Price
0 @ 0.000p

Concepta Key Personnel

CEO Erik Henau
COO David Darrock
CEO Penelope McCormick

Top of Page